Kuwait Investment Opportunities Fund sells stake in Elaj Medical Services


Kuwait investment Opportunities Fund has sold its Elaj Medical Services KSCC to a consortium of doctors. No financial terms were disclosed. NBK Capital advised the fund on the transaction while Meysan Partners provided the legal counsel. EMS owns Taiba Hospital in Kuwait.

PRESS RELEASE

NBK Capital, a leading investment firm in the MENA region, announced today that it has successfully completed the sale of a stake held by the Kuwait Investment Opportunities Fund in Elaj Medical Services KSCC (“EMS”), which owns Taiba Hospital in Kuwait, to a consortium of renowned doctors.

NBK Capital arranged the strategic investment in EMS in 2011, through its management of the Kuwait Investment Opportunities Fund (the “Fund”). The firm’s subsidiary in the DIFC, NBK Capital Partners Limited, has previously advised on successful investments in the healthcare sector, namely in Dünya Göz, a leading ophthalmology hospital chain in Turkey, and Bavet İlaç A.S., a leading manufacturer and distributor of animal health products in Turkey.

Taiba Hospital was founded in 2002 as a day case surgery center by Dr. Sanad Al-Fadala. During its partnership with NBK Capital and the Fund, the management team developed and executed a strategic growth plan that significantly expanded the hospital’s capacity and delivered high standards of clinical care to over 275,000 patients annually.

Commenting on the sale, Faisal Al Hamad, CEO of NBK Capital, said: “This deal represents the continuing endeavor of NBK Capital to develop the social infrastructure of Kuwait in partnership with local entrepreneurs. With enhanced service offerings and new facilities, we believe the business has a strong and sustainable platform to continue its expansion in Kuwait. We continue to explore credit and equity opportunities in core sectors such as healthcare, education and food & beverage, where we can leverage our expertise to maximize value for both our partners and investors.”

Dr. Sanad Al-Fadala, Founder and Chairman of Elaj Medical Services, welcomed the transaction: “We are excited to embark on the next phase of growth with our new partners who come with a wealth of experience in the medical field and bring strategic value to Taiba Hospital. Our partnership with NBK Capital has enabled us to grow our operations and facilities, and the new partnership will enable us to utilize our new state-of-the-art facilities to their full potential.”

The sellers were advised by NBK Capital’s Investment Banking team and Meysan Partners acted as legal advisor on the transaction.

About NBK Capital
NBK Capital, a leading investment company in the region, sets the standard in growth-focused innovative financial products and services. A world-class investment house, NBK Capital’s customer-centric approach provides forward-thinking solutions that address the specific investment needs of clients and investors, institutional customers and high-net-worth individuals.

NBK Capital leverages local and regional experience and expertise by combining the strengths, resources and global network of the National Bank of Kuwait SAK, one of the largest and oldest financial institutions in the region, with best-in-class investment structuring and execution, on a broad array of financial strategies to consistently deliver integrated value-added solutions.

Innovative products, objective research, creative thinking, timely implementation and excellence in service are the standards of quality of NBK Capital.

Operating regionally from Kuwait, Dubai, Istanbul and Cairo, and with over 175 investment professionals, NBK Capital prides itself on a reach and scale that is global, a presence that is regional and a service level that always remains personal.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.